Selective reduction of KCNA4 in vulnerable glutamatergic–serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease
Alzheimer's & Dementia · 2026-05 · 22 (5)
DOI: 10.1002/alz.71317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 12.05.2026. Verfasst von Louis J Kolling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Dorsal Raphe Nucleus, Serotonergic Neurons, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIAAA NIH HHS, Iowa Neuroscience Institute Research Program of Excellence (RPOE).
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Our previous studies demonstrate that htau mice recapitulate many of the neuropsychiatric features of early Alzheimer's disease (AD), and that the dorsal raphe nucleus (DRN) contains distinct subregions. Herein, we investigate the vulnerability of the centromedial DRN to pathologically phosphorylated tau (p‐tau), a region composed predominantly of dually serotonergic/glutamatergic (5HT/glut) neurons. METHODS We use a battery of computational, molecular, biophysical, and behavioral techniques to assess molecular changes in the centromedial DRN across preclinical and post mortem settings. RESULTS The centromedial DRN contains 5HT/glut neurons that differentially express ion‐channel genes in the htau mouse. This is associated with increased neuronal excitability, which may promote p‐tau accumulation. At Braak II, KCNA4 is reduced in 5HT/glut neurons in AD, which are especially vulnerable to p‐tau compared to 5HT‐nonglut neurons. DISCUSSION Tau‐mediated dysfunction of the DRN may be driven by changes in ion channel activity that concomitantly promote the spread of p‐tau in Braak progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Pharmacology, University of Iowa, Iowa City, Iowa, USA.
- Department of Cellular and Systems Pharmacology, University of Florida, Gainesville, Florida, USA.
- Department of Pathology, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Louis J Kolling, Catherine Anne Marcinkiewcz
Förderung
- NIA NIH HHS
- NIAAA NIH HHS
- Iowa Neuroscience Institute Research Program of Excellence (RPOE)
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Aging
Zitieren
APA
Kolling, L. J., Balasubramanian, N., Ismail, S., Feller, A. J., Alberhasky, J. M. H., Wang, R., Jennings, L., Hefti, M., & Marcinkiewcz, C. A. (2026). Selective reduction of KCNA4 in vulnerable glutamatergic–serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease. Alzheimer's & Dementia, 22(5). https://doi.org/10.1002/alz.71317
Vancouver
Kolling LJ, Balasubramanian N, Ismail S, Feller AJ, Alberhasky JMH, Wang R, et al. Selective reduction of KCNA4 in vulnerable glutamatergic–serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease. Alzheimer's & Dementia. 2026;22(5). doi:10.1002/alz.71317
BibTeX
@article{Kolling2026,
author = {Kolling, Louis J and Balasubramanian, Nagalakshmi and Ismail, Shafa and Feller, Alexander J and Alberhasky, Jessica Marie Hunter and Wang, Ruixiang and Jennings, Luke and Hefti, Marco and Marcinkiewcz, Catherine Anne},
title = {Selective reduction of KCNA4 in vulnerable glutamatergic–serotonin neurons of the dorsal raphe nucleus in Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {5},
doi = {10.1002/alz.71317}
}
EUVIMED